Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
-1.92%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$70.7B
AUM Growth
+$2.25B
(+3.3%)
Cap. Flow
+$4.31B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
4,336
New
249
Increased
2,450
Reduced
1,387
Closed
164
Top Buys
Top Sells
| 1 |
iShares Russell Top 200 Growth ETF
IWY
|
$146M |
| 2 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
$63.9M |
| 3 |
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
$41.5M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$30.6M |
| 5 |
Vanguard Growth ETF
VUG
|
$25.6M |
Sector Composition
| 1 | Technology | 11.47% |
| 2 | Financials | 5.65% |
| 3 | Consumer Discretionary | 3.85% |
| 4 | Healthcare | 3.59% |
| 5 | Industrials | 3.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Brilliant Earth
BRLT
$41.3M
| $31K | ﹤0.01% |
19,390
| – | – |
|
4102
Lightwave Logic
LWLG
$423M
| $31K | ﹤0.01% |
30,530
+20
| +0.1% | +$20 |
|
4103
Creative Realities
CREX
$24.6M
| $29K | ﹤0.01% |
15,100
| – | – |
|
4104
Immix Biopharma
IMMX
$62M
| $29K | ﹤0.01% |
17,040
-8,820
| -34% | -$15K |
|
4105
VYNE Therapeutics
VYNE
$7.62M
| $29K | ﹤0.01% |
18,298
| – | – |
|
4106
Oxford Square Capital
OXSQ
$172M
| $28K | ﹤0.01% |
+10,797
| New | +$28K |
|
4107
Lineage Cell Therapeutics
LCTX
$279M
| $27K | ﹤0.01% |
58,708
| – | – |
|
|
UBX
4108
DELISTED
Unity Biotechnology
UBX
| $27K | ﹤0.01% |
26,112
+1,880
| +8% | +$1.94K |
|
|
MKZR
4109
MacKenzie Realty Capital, Inc. Common Stock
MKZR
$9.67M
| $27K | ﹤0.01% |
1,797
-642
| -26% | -$9.65K |
|
4110
BARK
BARK
$149M
| $26K | ﹤0.01% |
19,051
-1,100
| -5% | -$1.5K |
|
|
GP
4111
GreenPower Motor Co
GP
$7.15M
| $26K | ﹤0.01% |
53,023
+300
| +0.6% | +$147 |
|
4112
Denison Mines
DNN
$2.11B
| $25K | ﹤0.01% |
19,464
-500
| -3% | -$642 |
|
|
LGVN
4113
Longeveron
LGVN
$16.5M
| $25K | ﹤0.01% |
15,955
+3,500
| +28% | +$5.48K |
|
4114
MIRA Pharmaceuticals
MIRA
$26.7M
| $25K | ﹤0.01% |
25,547
+10,475
| +69% | +$10.3K |
|
|
FLNT
4115
Fluent
FLNT
$53.1M
| $24K | ﹤0.01% |
11,112
| – | – |
|
4116
Gores Guggenheim
PSNY
$2.14B
| $24K | ﹤0.01% |
23,322
-2,350
| -9% | -$2.42K |
|
|
UROY
4117
Uranium Royalty Corp
UROY
$437M
| $24K | ﹤0.01% |
13,761
| – | – |
|
4118
Aclaris Therapeutics
ACRS
$227M
| $22K | ﹤0.01% |
14,694
| – | – |
|
4119
Clearside Biomedical
CLSD
$27.2M
| $21K | ﹤0.01% |
22,500
+12,500
| +125% | +$11.7K |
|
4120
Editas Medicine
EDIT
$248M
| $21K | ﹤0.01% |
18,387
-441
| -2% | -$504 |
|
4121
W&T Offshore
WTI
$261M
| $20K | ﹤0.01% |
13,008
+1,013
| +8% | +$1.56K |
|
4122
American Battery Technology Co
ABAT
$222M
| $19K | ﹤0.01% |
18,831
+1,110
| +6% | +$1.12K |
|
|
BITF
4123
Bitfarms
BITF
$713M
| $19K | ﹤0.01% |
24,360
+255
| +1% | +$199 |
|
4124
Microvision
MVIS
$334M
| $19K | ﹤0.01% |
15,552
-975
| -6% | -$1.19K |
|
4125
Cognition Therapeutics
CGTX
$230M
| $18K | ﹤0.01% |
41,665
-49,000
| -54% | -$21.2K |
|